# A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX

> **NCT00319592** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 60 (actual)

## Conditions studied

- Japanese Encephalitis

## Interventions

- **BIOLOGICAL:** ChimeriVax™-JE vaccine
- **BIOLOGICAL:** JE-VAX® vaccine

## Key facts

- **NCT ID:** NCT00319592
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2006-09
- **Final completion:** 2006-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2012-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00319592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00319592, "A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00319592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*